SEC Form 4 research
| Issuer | Zenas BioPharma, Inc. |
|---|---|
| Tickers | ZBIO |
| Reporting owners | 23 |
| Officers and directors | 10 |
| Last public filing | 2026-09-03 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-02 | 2026-09-01 | Oliger Christy J. | A | 37,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.